Page last updated: 2024-09-04

lonafarnib and ritonavir

lonafarnib has been researched along with ritonavir in 3 studies

Compound Research Comparison

Studies
(lonafarnib)
Trials
(lonafarnib)
Recent Studies (post-2010)
(lonafarnib)
Studies
(ritonavir)
Trials
(ritonavir)
Recent Studies (post-2010) (ritonavir)
22434905,4191,2912,772

Protein Interaction Comparison

ProteinTaxonomylonafarnib (IC50)ritonavir (IC50)
Solute carrier organic anion transporter family member 2B1 Homo sapiens (human)6.1
Bile salt export pumpHomo sapiens (human)2.085
ATP-dependent translocase ABCB1Homo sapiens (human)2.65
Cytochrome P450 3A4Homo sapiens (human)0.1623
Cytochrome P450 2D6Homo sapiens (human)2.3
Cytochrome P450 2C9 Homo sapiens (human)2.458
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (NEW YORK-5 ISOLATE)0.067
Substance-K receptorHomo sapiens (human)2.622
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)2.35
Thromboxane-A synthase Homo sapiens (human)0.076
Multidrug and toxin extrusion protein 2Homo sapiens (human)4.4
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.1933
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.4
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)2
Protease Human immunodeficiency virus 14.9253

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bozdayi, AM; Çalişkan, A; Glenn, JS; Heller, T; Idilman, R; Kalkan, Ç; Karakaya, F; Karatayli, E; Karatayli, S; Keskin, O; Koh, C; Yurdaydin, C1
Apelian, D; Bozdayi, AM; Çalişkan, A; Choong, I; Glenn, JS; Heller, T; Idilman, R; Kalkan, Ç; Karakaya, F; Karatayli, E; Karatayli, S; Keskin, O; Koh, C; Önem, S; Yurdaydin, C; Yurdcu, E1
Keskin, O; Yurdaydin, C1

Trials

2 trial(s) available for lonafarnib and ritonavir

ArticleYear
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study.
    Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:4

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon-alpha; Male; Middle Aged; Pilot Projects; Piperidines; Pyridines; Ritonavir; RNA, Viral; Treatment Outcome; Young Adult

2018
A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.
    Hepatology (Baltimore, Md.), 2022, Volume: 75, Issue:6

    Topics: Alanine Transaminase; Drug Therapy, Combination; Hepatitis D, Chronic; HIV Infections; Humans; Interferon-alpha; Piperidines; Pyridines; Ritonavir; RNA

2022

Other Studies

1 other study(ies) available for lonafarnib and ritonavir

ArticleYear
Emerging drugs for hepatitis D.
    Expert opinion on emerging drugs, 2023, Volume: 28, Issue:2

    Topics: Antiviral Agents; Hepatitis D; Hepatitis D, Chronic; Humans; Nucleic Acids; Polyethylene Glycols; Polymers; Ritonavir; Treatment Outcome

2023